?9-THC-induced cognitive deficits in mice are reversed by the GABAA antagonist bicuculline
- 20 August 2004
- journal article
- research article
- Published by Springer Nature in Psychopharmacology
- Vol. 178 (2-3) , 317-327
Abstract
Rationale The results of recent in vitro studies have underscored the important role that activation of CB1 receptors has on GABAergic activity in brain areas associated with memory. Objectives The primary purpose of this study was to test the hypothesis that the memory disruptive effects of Δ9-tetrahydrocannabinol (Δ9-THC) in vivo are mediated through GABAergic systems. Conversely, we also evaluated whether blocking CB1 receptor signaling would alter memory deficits elicited by GABA agonists. Methods The GABAA antagonist bicuculline and GABAB antagonist CGP 36742 were evaluated for their ability to ameliorate Δ9-THC-induced deficits in a mouse working memory Morris water maze task. Mice were also assessed in a T-maze task, as well as non-cognitive behavioral assays. Additionally, the effects of GABAA and GABAB agonists were assessed in either CB1 (−/−) mice or wild type mice treated with the CB1 antagonist SR 141716. Results Memory deficits resulting from 10 mg/kg Δ9-THC in the Morris water maze were completely reversed by bicuculline, though unaffected by CGP 36742. Bicuculline also blocked the disruptive effects of Δ9-THC in the T-maze, but failed to alter non-mnemonic effects of Δ9-THC. Although CB1 (−/−) mice exhibited supersensitivity to muscimol-induced water maze deficits compared with wild type control mice, muscimol elicited virtually identical effects in SR 141716-treated and vehicle-treated wild type mice. Conclusions This is the first demonstration of which we are aware showing that GABAA receptors may play a necessary role in Δ9-THC-induced memory impairment in whole animals.Keywords
This publication has 28 references indexed in Scilit:
- Intracerebral microinjections of Δ9-tetrahydrocannabinol: search for the impairment of spatial memory in the eight-arm radial maze in ratsBrain Research, 2002
- Δ9-Tetrahydrocannabinol decreases extracellular GABA and increases extracellular glutamate and dopamine levels in the rat prefrontal cortex: an in vivo microdialysis studyBrain Research, 2002
- Cannabinoid receptor agonist WIN 55,212‐2 inhibits rat cortical dialysate γ‐aminobutyric acid levelsJournal of Neuroscience Research, 2001
- Presynaptic Specificity of Endocannabinoid Signaling in the HippocampusNeuron, 2001
- Functional expression of cell surface cannabinoid CB1 receptors on presynaptic inhibitory terminals in cultured rat hippocampal neuronsNeuroscience, 2000
- Transgenic studies of painPain, 1998
- Action of δ-9-tetrahydrocannabinol on gabaa receptor-mediated responses in a grease-gap recording preparation of the rat hippocampal sliceNeuropharmacology, 1997
- Δ9-tetrahydrocannabinol and anandamide enhance the ability of muscimol to induce catalepsy in the globus pallidus of ratsEuropean Journal of Pharmacology, 1993
- An investigation of the involvement of GABA in certain pharmacological effects of delta-9-tetrahydrocannabinolPharmacology Biochemistry and Behavior, 1991
- Drugs which stimulate or facilitate central GABAergic transmission interact synergistically with delta-9-tetrahydrocannabinol to produce marked catalepsy in miceNeuropharmacology, 1988